Welcome to our dedicated page for VALUENCE MERGER I SEC filings (Ticker: VMCAU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on VALUENCE MERGER I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into VALUENCE MERGER I's regulatory disclosures and financial reporting.
Valuence Merger Corp. I is a Cayman Islands blank check company formed to complete a Business Combination, targeting Asian life sciences or sustainable technology businesses. The company has not commenced operations and derives non-operating income from interest on proceeds held in a trust.
At June 30, 2025 the company reported $22.713 million in a Trust Account and $92,661 in cash, total assets of $22.851 million, total liabilities of $12.896 million and a shareholders’ deficit of $(12.758) million. Working capital deficit was $4.652885 million. Interest earned on the Trust Account materially contributed to reported net income of $58,716 for the quarter and $83,692 for the six months, while deferred underwriting fees of $8.10548 million and Class A shares subject to redemption of $22.713 million represent significant obligations. The company received a Nasdaq listing-notice and trading was suspended, with trading subsequently moving to the over-the-counter market, and management disclosed substantial doubt about the company’s ability to continue as a going concern absent a Business Combination or further sponsor/related-party support.
Valuence Merger Corp. I (VMCAU) 8-K: The Board approved the 13th of up to 19 one-month extensions to consummate its initial business combination. The deadline moves from 3 Aug 2025 to 3 Sep 2025.
Per its charter, the SPAC may continue extending monthly through 3 Mar 2026. To effect the latest extension the Company deposited an additional $28,011 into the trust account, maintaining the per-share cash amount for public shareholders.
No target has yet been announced and no other financial results were disclosed.
Nasdaq Stock Market LLC has filed a Form 25 with the U.S. Securities and Exchange Commission to remove Valuence Merger Corp. I (symbol: VMCAU) securities from listing and registration under Section 12(b) of the Exchange Act.
- Securities affected: Class A Ordinary Shares, Warrants and Units.
- Date filed: 11 July 2025.
- Regulatory basis: Exchange cites Rule 12d2-2(b), confirming it has followed its own rules to strike the securities; the issuer may also rely on Rule 12d2-2(c) for voluntary withdrawal.
- Signatory: Aravind Menon, Hearings Advisor, on behalf of Nasdaq.
This notice means the company’s securities will no longer trade on Nasdaq once the delisting becomes effective, and the registration of the securities under Section 12(b) will be withdrawn.
FAQ
What is the current stock price of VALUENCE MERGER I (VMCAU)?
